Carly Mcateer, MD | |
301c Us Route 1, Scarborough, ME 04074-9701 | |
(207) 396-8600 | |
(207) 396-8632 |
Full Name | Carly Mcateer |
---|---|
Gender | Female |
Speciality | Family Practice |
Experience | 17 Years |
Location | 301c Us Route 1, Scarborough, Maine |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1699974311 | NPI | - | NPPES |
1699974311 | Medicaid | ME |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | MD18534 (Maine) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Maine Medical Center | Portland, ME | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Maine Medical Partners | 9335043967 | 789 |
Mainehealth | 7517860588 | 2067 |
News Archive
Researchers have created the first mouse model demonstrating the role of a cancer promoting gene, Astrocyte elevated gene-1 (AEG-1), in hepatocellular carcinoma, or liver cancer. The mouse model represents a critical step in understanding the molecular mechanisms of liver cancer progression and could lead to novel therapies for the disease.
Baxter International Inc. announced today that it has entered into a definitive agreement to divest its U.S. generic injectables business to Hikma Pharmaceuticals PLC. The consideration for the divestiture arrangement totals approximately $112 million, subject to closing adjustments.
Cintas Corporation, a leader in first-aid and safety products, today announced the availability of GlucoBurst, a blood sugar control product for its first-aid cabinets. According to the Centers for Disease Control and Prevention (CDC), diabetes results in 15 million missed work days and 120 million work days with reduced performance each year.
In a study by Yale Cancer Center, researchers report on the discovery of a new role for STimulator of INterferon Genes or STING.
Amgen today announced a decision to stop the ganitumab (AMG 479) Phase 3 GAMMA (Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas) trial following the recommendation of an independent Data Monitoring Committee (DMC) overseeing the trial.
› Verified 6 days ago
Entity Name | Maine Medical Partners |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1467477349 PECOS PAC ID: 9335043967 Enrollment ID: O20031125000026 |
News Archive
Researchers have created the first mouse model demonstrating the role of a cancer promoting gene, Astrocyte elevated gene-1 (AEG-1), in hepatocellular carcinoma, or liver cancer. The mouse model represents a critical step in understanding the molecular mechanisms of liver cancer progression and could lead to novel therapies for the disease.
Baxter International Inc. announced today that it has entered into a definitive agreement to divest its U.S. generic injectables business to Hikma Pharmaceuticals PLC. The consideration for the divestiture arrangement totals approximately $112 million, subject to closing adjustments.
Cintas Corporation, a leader in first-aid and safety products, today announced the availability of GlucoBurst, a blood sugar control product for its first-aid cabinets. According to the Centers for Disease Control and Prevention (CDC), diabetes results in 15 million missed work days and 120 million work days with reduced performance each year.
In a study by Yale Cancer Center, researchers report on the discovery of a new role for STimulator of INterferon Genes or STING.
Amgen today announced a decision to stop the ganitumab (AMG 479) Phase 3 GAMMA (Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas) trial following the recommendation of an independent Data Monitoring Committee (DMC) overseeing the trial.
› Verified 6 days ago
Entity Name | Mainehealth |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1639194509 PECOS PAC ID: 7517860588 Enrollment ID: O20040206000472 |
News Archive
Researchers have created the first mouse model demonstrating the role of a cancer promoting gene, Astrocyte elevated gene-1 (AEG-1), in hepatocellular carcinoma, or liver cancer. The mouse model represents a critical step in understanding the molecular mechanisms of liver cancer progression and could lead to novel therapies for the disease.
Baxter International Inc. announced today that it has entered into a definitive agreement to divest its U.S. generic injectables business to Hikma Pharmaceuticals PLC. The consideration for the divestiture arrangement totals approximately $112 million, subject to closing adjustments.
Cintas Corporation, a leader in first-aid and safety products, today announced the availability of GlucoBurst, a blood sugar control product for its first-aid cabinets. According to the Centers for Disease Control and Prevention (CDC), diabetes results in 15 million missed work days and 120 million work days with reduced performance each year.
In a study by Yale Cancer Center, researchers report on the discovery of a new role for STimulator of INterferon Genes or STING.
Amgen today announced a decision to stop the ganitumab (AMG 479) Phase 3 GAMMA (Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas) trial following the recommendation of an independent Data Monitoring Committee (DMC) overseeing the trial.
› Verified 6 days ago
Entity Name | Maine Medical Partners |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1598780447 PECOS PAC ID: 9335043967 Enrollment ID: O20040220000847 |
News Archive
Researchers have created the first mouse model demonstrating the role of a cancer promoting gene, Astrocyte elevated gene-1 (AEG-1), in hepatocellular carcinoma, or liver cancer. The mouse model represents a critical step in understanding the molecular mechanisms of liver cancer progression and could lead to novel therapies for the disease.
Baxter International Inc. announced today that it has entered into a definitive agreement to divest its U.S. generic injectables business to Hikma Pharmaceuticals PLC. The consideration for the divestiture arrangement totals approximately $112 million, subject to closing adjustments.
Cintas Corporation, a leader in first-aid and safety products, today announced the availability of GlucoBurst, a blood sugar control product for its first-aid cabinets. According to the Centers for Disease Control and Prevention (CDC), diabetes results in 15 million missed work days and 120 million work days with reduced performance each year.
In a study by Yale Cancer Center, researchers report on the discovery of a new role for STimulator of INterferon Genes or STING.
Amgen today announced a decision to stop the ganitumab (AMG 479) Phase 3 GAMMA (Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas) trial following the recommendation of an independent Data Monitoring Committee (DMC) overseeing the trial.
› Verified 6 days ago
Entity Name | Maine Medical Partners |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1134144090 PECOS PAC ID: 9335043967 Enrollment ID: O20040331000191 |
News Archive
Researchers have created the first mouse model demonstrating the role of a cancer promoting gene, Astrocyte elevated gene-1 (AEG-1), in hepatocellular carcinoma, or liver cancer. The mouse model represents a critical step in understanding the molecular mechanisms of liver cancer progression and could lead to novel therapies for the disease.
Baxter International Inc. announced today that it has entered into a definitive agreement to divest its U.S. generic injectables business to Hikma Pharmaceuticals PLC. The consideration for the divestiture arrangement totals approximately $112 million, subject to closing adjustments.
Cintas Corporation, a leader in first-aid and safety products, today announced the availability of GlucoBurst, a blood sugar control product for its first-aid cabinets. According to the Centers for Disease Control and Prevention (CDC), diabetes results in 15 million missed work days and 120 million work days with reduced performance each year.
In a study by Yale Cancer Center, researchers report on the discovery of a new role for STimulator of INterferon Genes or STING.
Amgen today announced a decision to stop the ganitumab (AMG 479) Phase 3 GAMMA (Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas) trial following the recommendation of an independent Data Monitoring Committee (DMC) overseeing the trial.
› Verified 6 days ago
Entity Name | Mainehealth |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1790265502 PECOS PAC ID: 7517860588 Enrollment ID: O20040701000166 |
News Archive
Researchers have created the first mouse model demonstrating the role of a cancer promoting gene, Astrocyte elevated gene-1 (AEG-1), in hepatocellular carcinoma, or liver cancer. The mouse model represents a critical step in understanding the molecular mechanisms of liver cancer progression and could lead to novel therapies for the disease.
Baxter International Inc. announced today that it has entered into a definitive agreement to divest its U.S. generic injectables business to Hikma Pharmaceuticals PLC. The consideration for the divestiture arrangement totals approximately $112 million, subject to closing adjustments.
Cintas Corporation, a leader in first-aid and safety products, today announced the availability of GlucoBurst, a blood sugar control product for its first-aid cabinets. According to the Centers for Disease Control and Prevention (CDC), diabetes results in 15 million missed work days and 120 million work days with reduced performance each year.
In a study by Yale Cancer Center, researchers report on the discovery of a new role for STimulator of INterferon Genes or STING.
Amgen today announced a decision to stop the ganitumab (AMG 479) Phase 3 GAMMA (Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas) trial following the recommendation of an independent Data Monitoring Committee (DMC) overseeing the trial.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Carly Mcateer, MD 272 Congress St, Portland, ME 04101-3637 Ph: (207) 874-2466 | Carly Mcateer, MD 301c Us Route 1, Scarborough, ME 04074-9701 Ph: (207) 396-8600 |
News Archive
Researchers have created the first mouse model demonstrating the role of a cancer promoting gene, Astrocyte elevated gene-1 (AEG-1), in hepatocellular carcinoma, or liver cancer. The mouse model represents a critical step in understanding the molecular mechanisms of liver cancer progression and could lead to novel therapies for the disease.
Baxter International Inc. announced today that it has entered into a definitive agreement to divest its U.S. generic injectables business to Hikma Pharmaceuticals PLC. The consideration for the divestiture arrangement totals approximately $112 million, subject to closing adjustments.
Cintas Corporation, a leader in first-aid and safety products, today announced the availability of GlucoBurst, a blood sugar control product for its first-aid cabinets. According to the Centers for Disease Control and Prevention (CDC), diabetes results in 15 million missed work days and 120 million work days with reduced performance each year.
In a study by Yale Cancer Center, researchers report on the discovery of a new role for STimulator of INterferon Genes or STING.
Amgen today announced a decision to stop the ganitumab (AMG 479) Phase 3 GAMMA (Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas) trial following the recommendation of an independent Data Monitoring Committee (DMC) overseeing the trial.
› Verified 6 days ago
Mr. Gavin M Ducker, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 300 Professional Dr Ste 2c, Scarborough, ME 04074 Phone: 207-883-7926 | |
Mrs. Kristyn Michelle Kee, FNP-C Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 96 Campus Dr, Scarborough, ME 04074 Phone: 603-303-0108 | |
Kristen Alyse Scopaz, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 20 Mussey Rd, Scarborough, ME 04074 Phone: 207-885-1333 Fax: 207-885-1332 | |
Gwendolyn Oguin, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 20 Mussey Rd, Suite 2, Scarborough, ME 04074 Phone: 207-885-1333 Fax: 207-885-1337 | |
Dr. David Merrill, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 69 Us Route 1, 6 Nonesuch Rd, Scarborough, ME 04074 Phone: 207-883-8100 | |
Felicia Jo Munster, FNP-BC Family Medicine Medicare: Medicare Enrolled Practice Location: 100 Campus Dr, Scarborough, ME 04074 Phone: 207-396-7683 Fax: 207-396-7684 | |
Dr. Howard Manning Chase, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 438 Us Route 1, Scarborough, ME 04074 Phone: 207-883-4124 Fax: 207-883-0732 |